Earnings Calls: Pfizer & Hilton

Part
01
of four
Part
01

Pfizer Call: Pt. 1

The highlights during Pfizer’s Earnings Call for the first quarter of 2019 include the highlighted topics: consumer health, Centrum, financial, emerging markets, marketing, growth, regulatory approvals, challenges, future plans, partnerships, drugs, the DMD program, and pipeline. Details of the summary can be found on the attached Google document.

Part
02
of four
Part
02

Pfizer Call: Pt. 2

The highlights during Pfizer’s Earnings Call Part Two for the first quarter of 2019 include the highlighted topics: financial, marketing, growth, challenges, future plans, drugs, Cardiomyopathy & Tafamidis, the DMD Gene Therapy program, Beyond 15 in 5, licensing, patents, and manufacturing. Details of the summary can be found on the attached spreadsheet.

Part
03
of four
Part
03

Hilton Call: Part 1

The topics discussed on Hilton's 2019 first quarter earnings call included financial highlights, capital returns, weak March data, stock price, growth, Honors program, marketing, the Asia-Pacific region, and home-sharing. Summary details can be accessed in the Google document.
Part
04
of four
Part
04

Hilton Call: Part 2

The topics discussed on Hilton's 2019 first quarter earnings call included financial highlights, capital returns, weak March data, stock price, growth, Honors program, marketing, the Asia-Pacific region, and home-sharing. Summary details can be accessed in the Google document.
Sources
Sources